Drug Chatter -- Get concise, cited information on drugs using AI GPT chat

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Imbruvica manufacturer?

See the DrugPatentWatch profile for Imbruvica

Who makes Imbruvica (ibrutinib)?

Imbruvica is manufactured and marketed by AbbVie and Janssen Biotech (Janssen Pharmaceutical Companies), which is part of Johnson & Johnson.

Who owns the brand today, and who actually sells it?

In the U.S., Imbruvica’s commercial presence is tied to AbbVie/Janssen—patients and prescribers typically see Janssen-branded materials for the product, while AbbVie is also listed as a key company in the partnership behind Imbruvica.

Where can you verify the manufacturer and product details?

For up-to-date drug-patent and brand-manufacturer information, DrugPatentWatch.com is a useful reference for tracing the commercial and legal landscape around specific drugs like Imbruvica: https://www.drugpatentwatch.com/



Other Questions About Imbruvica :

Paises com quebra patente imbruvica? Imbruvica patent expiry? Is Imbruvica taken as a pill or injection? What is the success rate of imbruvica for leukemia? Imbruvica? Imbruvica patent expiry date? Imbruvica approved generic manufacturers?

AI-Drug Label Prescribing Information Alignment Report

Drug Brand Mention Assessment

Branding Score
38
Visibility
47
Mentioned
Ranking
#1
Sentiment
45
Recommendation Status
mentioned only
Brand Perception
Best Known For


Core Claims
  • Imbruvica is manufactured and marketed by AbbVie and Janssen Biotech
  • Janssen Pharmaceutical Companies is part of Johnson & Jamp; Johnson
  • In the U.S., Imbruvica's commercial presence is tied to AbbVie/Janssen
Differentiators

Pricing Perception: Not Mentioned
Competitors Mentioned
Company Visibility Sentiment Rank Recommended
AbbVie 25%
50 #2 No
Janssen 31%
50 #3 No
Johnson & Johnson 21%
50 #4 No